Schizophrenia is a serious mental illness that requires treatment with medication to lessen symptoms. But even if your symptoms go away, you'll need to stay on treatment to avoid a relapse.

The U.S. Food and Drug Administration approved a new schizophrenia treatment on Thursday for the first time in decades, offering an alternative to the antipsychotic medications those with the ...

has approved Cobenfy (xanomeline/trospium chloride), a new medication offering a novel approach to treating schizophrenia, marking the first new type of schizophrenia drug in decades. Cobenfy ...

Cobenfy was approved by the Food and Drug Administration in fall 2024 and represents the first novel approach in decades to treating schizophrenia, which affects an estimated 3.7 million American ...